These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 17010737

  • 1. Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients.
    Malaviya R, Sun Y, Tan JK, Wang A, Magliocco M, Yao M, Krueger JG, Gottlieb AB.
    J Am Acad Dermatol; 2006 Oct; 55(4):590-7. PubMed ID: 17010737
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept].
    Mahiques L, Pitarch G, Sánchez-Carazo JL, Pérez-Ferriols A, Soriano CJ, Alegre V.
    Actas Dermosifiliogr; 2007 Oct; 98(8):539-44. PubMed ID: 17919428
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A, Esposito M, Costanzo A, Chimenti S.
    Am J Clin Dermatol; 2009 Oct; 10(5):319-24. PubMed ID: 19658444
    [Abstract] [Full Text] [Related]

  • 4. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
    Günther C, Blau K, Förster U, Viehweg A, Wozel G, Schäkel K.
    Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S, Gordon KB, Poulin Y, Langley RG, Gottlieb AB, Dunn M, Jahreis A.
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [Abstract] [Full Text] [Related]

  • 6. Treatment of erythrodermic psoriasis with etanercept.
    Esposito M, Mazzotta A, de Felice C, Papoutsaki M, Chimenti S.
    Br J Dermatol; 2006 Jul; 155(1):156-9. PubMed ID: 16792768
    [Abstract] [Full Text] [Related]

  • 7. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F.
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [Abstract] [Full Text] [Related]

  • 8. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
    Tatlican S, Arikok A, Gulbahar O, Eren C, Cevirgen B, Eskioglu F.
    J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
    [Abstract] [Full Text] [Related]

  • 9. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K, Rogers S.
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [Abstract] [Full Text] [Related]

  • 10. A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis.
    Moore A, Gordon KB, Kang S, Gottlieb A, Freundlich B, Xia HA, Stevens SR.
    J Am Acad Dermatol; 2007 Apr; 56(4):598-603. PubMed ID: 17113190
    [Abstract] [Full Text] [Related]

  • 11. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
    Koc E, Tunca M, Akgul EO, Akar A, Kurt Y, Kurumlu Z, Erbil K, Kilic S.
    J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept.
    Ortonne JP, Taïeb A, Ormerod AD, Robertson D, Foehl J, Pedersen R, Molta C, Freundlich B.
    Br J Dermatol; 2009 Nov; 161(5):1190-5. PubMed ID: 19566665
    [Abstract] [Full Text] [Related]

  • 15. [Clinical experience with etanercept in the treatment of psoriasis].
    Martín B, Sánchez-Carazo JL, Pérez-Ferriols A, Laguna C, Oliver V, Alegre V.
    Actas Dermosifiliogr; 2008 Sep; 99(7):540-5. PubMed ID: 18682167
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
    Gisondi P, Cotena C, Tessari G, Girolomoni G.
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
    [Abstract] [Full Text] [Related]

  • 17. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.
    Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Stramazzotti D, Morichetti D, Bernardini ML, Mannello B, Fabris G, Offidani A.
    Br J Dermatol; 2007 Dec; 157(6):1155-60. PubMed ID: 17916208
    [Abstract] [Full Text] [Related]

  • 18. Etanercept in the treatment and retreatment of psoriasis in daily clinical practice.
    Barrera MV, Habicheyn S, Mendiola MV, Herrera Ceballos E.
    Eur J Dermatol; 2008 Dec; 18(6):683-7. PubMed ID: 19049936
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
    Cecchi R, Bartoli L.
    Dermatol Online J; 2006 Dec 10; 12(7):4. PubMed ID: 17459290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.